Review of operative considerations in spinal cord stem cell therapy

来源 :世界干细胞杂志:英文版(电子版) | 被引量 : 0次 | 上传用户:darklbueyz
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Spinal cord injury(SCI)can permanently impair motor and sensory function and has a devastating cost to patients and the United States healthcare system.Stem cell transplantation for treatment of SCI is a new technique aimed at creating biological function
其他文献
Diabetes,one of the most common chronic diseases in the modern world,has pancreaticβcell deficiency as a major part of its pathophysiological mechanism.Pancrea
BACKGROUND The implementation of nutritional strategies targeting several variables at once could benefit patients with cirrhosis.Non-alcoholic beer has differe
BACKGROUND Lenvatinib has been shown to be noninferior to sorafenib regarding prognosis and recurrence rate in patients with unresectable hepatocellular carcino
BACKGROUND Parkinson’s disease(PD)is a neurological disorder characterized by the progressive loss of midbrain dopamine(DA)neurons.Bone marrow mesenchymal stem
Pneumonia is the inflammation of the lungs and it is the world’s leading cause of death for children under 5 years of age.The latest coronavirus disease 2019(C
BACKGROUND Hepatocellular carcinoma(HCC)is the most important primary malignant liver disease.A large proportion of patients with advanced HCC have macrovascula
BACKGROUND Collagen is one of the most commonly used natural biomaterials for tendon tissue engineering.One of the possible practical ways to further enhance te
The use of orthobiologics as a novel therapy for the treatment of numerous musculoskeletal disorders has increased considerably over the past decade.Currently,t
Coronavirus disease 2019(COVID-19)is caused by the novel coronavirus severe acute respiratory syndrome coronavirus-2(SARS-CoV-2).Systemic complications include
The high mortality rate of breast cancer is mainly caused by the metastatic ability of cancer cells,resistance to chemotherapy and radiotherapy,and tumor regres